[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 533
Citations 0
Correction
June 2014

Incorrect Value in Table

JAMA Neurol. 2014;71(6):803. doi:10.1001/jamaneurol.2014.1265

In the Viewpoint titled “Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?” published online January 6, 2014, and in the March issue of JAMA Neurology (2014;71[3]:269-270. doi:10.1001/jamaneurol.2013.5486), the Table contained a typographical error in the last column. The value for fingolimod in the composite clinical and radiographic disease activity free status should have been 33%. This article has been corrected online.

×